Condensed Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Revenue:
Product revenue	$ 251,210	$ 237,515	$ 483,313	$ 456,907
Service revenue	162,133	152,607	312,507	293,418
Total revenue	413,343	390,122	795,820	750,325
Cost of Revenue:
Cost of product revenue	91,203	86,956	174,573	164,998
Cost of service revenue	89,383	84,648	172,946	164,712
Total cost of revenue	180,586	171,604	347,519	329,710
Gross profit	232,757	218,518	448,301	420,615
Expenses:
Sales and marketing	75,217	68,020	150,353	135,868
General and administrative	44,920	41,846	87,519	82,935
Research and development	24,317	25,433	49,323	48,547
Income from operations	88,303	83,219	161,106	153,265
Interest expense	(7,259)	(2,965)	(13,563)	(5,739)
Interest income	559	488	984	959
Income before provision for income taxes	81,603	80,742	148,527	148,485
Provision for income taxes	24,665	23,498	45,011	44,648
Net income	56,938	57,244	103,516	103,837
Less: Net income attributable to noncontrolling interest	26	26	10	34
Net income attributable to IDEXX Laboratories, Inc. stockholders	$ 56,912	$ 57,218	$ 103,506	$ 103,803
Earnings per Share:
Basic	$ 0.61	$ 0.56	$ 1.10	$ 1.01
Diluted	$ 0.60	$ 0.55	$ 1.09	$ 1.00
Weighted Average Shares Outstanding:
Basic	93,384	102,250	93,829	102,739
Diluted	94,306	103,590	94,934	104,160